Product Details
Rapid Test Kit Coivd-19 (Colloidal Gold) Self-test
Product specifications
Product name | Rapid Test Kit Coivd-19 (Colloidal Gold) Self-test |
Application | Qualitative detection of nucleocapsid(N) protein antigen from
SARS-CoV-2 in human nasal (anterior) swab |
Main Composition | Test Cassette, Swab, Sample Extraction Bottle, Sample Extraction
Tube, Tube Cap, Dropper, IFU |
Test time | 15 minutes |
Keep temperature | 2-30℃ |
Shelf-life | 18 months |
Principle of the procedure
The SARS-CoV-2 Antigen Test Kit (GICA) uses the lateral flow
immuno-chromatographic sandwich assay to detect nucleocapsid
protein of SARS-CoV-2 in nasopharyngeal swabs or nasal swabs.
The patient sample is placed in the Sample Tube, during which time
the virus particles in the sample are disrupted, exposing internal
viral nucleoproteins. After disruption, the sample is dispensed
into the Test Cassette sample well. And the sample migrates through
a test strip, if the SARS-CoV-2 virus antigen is present, a red
color line will be showed on the T site. If SARS-CoV-2 viral
antigen is absent, there is not a red line will be showed on the T
site, however, a red line will be always showed on the C site
indicating that the reaction system is properly happened.
Application
This kit is used for in vitro qualitative detection of
nucleocapsid(N) protein antigen from SARS-CoV-2 in human nasal (anterior) swab.
This kit is authorized for home use with self-collected observed
direct nasal (anterior) swab from individuals aged 15 years or
older or adult collected nasal (anterior) swab from individuals
aged four years or older.
Company Profile
Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan
District, Shenzhen, P.R. China. is a diagnostics company focused on
the development and manufacture of IVD tests at the Point-of-Care
with highly innovative proprietary technology.
We focused on the emerging markets of in vitro pathological
diagnosis and immunodiagnosis. We developed, manufactured and
successfully launched the in vitro immunodiagnosis platform for
cancer and the POCT for infectious, genetic and chronic diseases.
<span style="color: rgb(33, 33, 33); text-transform: none;
text-indent: 0px; letter-spacing: normal;" initial;"="" initial;=""
0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;=""
!important;="" inline="" none;="" 600;="" 14px;="" sans-serif;=""
arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",=""
hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,=""
freesans,="" yahei",="" "microsoft="" helvetica,="" grande",=""
"lucida="" ui",="" segoe="">At Kissh we work every day to shape
the future of in-vitro diagnostic testing. And our people are our
best asset, the reason for our track record and our strength while
we are moving forward. We live by our fundamental values and
incorporate them in everything that we do. Our best asset is ‘Step
Forward Every Second’